Delivery Order SPE2DB24D2205-SPE2DB25FEGSJ
Award Date 8/22/25
Potential Completion Date 9/15/25
Potential Value $34K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a pharmaceutical product, with a ceiling value of $34,342.56 and a completion date of June 20, 2025. The contract is a firm-fixed-price delivery order, indicating the government is acquiring a specific quantity of a commercial product at an established price....
- This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,342.56, is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The contract is a delivery order with a firm fixed price of $48,673.20 and an ultimate completion date of August 29, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a...
- This federal contract award, valued at $32,448.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty medication, with a completion date of April 30, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TAKHZYRO 300 MG/2 ML SYRINGE 2ML, a specialty pharmaceutical product, with a ceiling value of $33,570.26 and an ultimate completion date of December 12, 2024. The contract is a Firm Fixed Price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical drug Takhzyro, a treatment for hereditary angioedema. The $32,448.80 firm fixed price delivery order was placed by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 30, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency awarded a $31,755 delivery order to Amerisourcebergen Drug Corporation for TAKHZYRO 300 MG/2 ML syringes. Under the firm fixed price contract, Amerisourcebergen will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by August 29, 2023 in support of DLA programs. No additional details were provided regarding the original solicitation or use of the products. Amerisourcebergen will perform as the prime contractor for this order...
- This federal contract award SPE2DB20D3103|SPE2DB24FN9R7 is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4564735336 - TAKHZYRO 300 MG/2 ML SYRINGE 2ML. The $32,448.80 firm fixed price contract has a completion date of June 17, 2024. The award is not set aside and is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,060.43 to AmerisourceBergen Drug Corp for the supply of TADLIQ 20 mg/5 ml suspension in 150ml quantities. This firm fixed-price, non-set-aside delivery order was awarded on July 31, 2025, with an ultimate completion date of August 1, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $47,268.96 for TUKYSA 150 mg tablets (120-count units) from the Defense Logistics Agency Medical Supply Chain. This competitive award, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, carries firm fixed pricing and represents a non-set-aside delivery order. The contract is performed at the vendor's Conshohocken location...